請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5515
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賴美淑 | |
dc.contributor.author | Wan-Hsuan Chang | en |
dc.contributor.author | 張婉暄 | zh_TW |
dc.date.accessioned | 2021-05-15T18:01:19Z | - |
dc.date.available | 2014-10-20 | |
dc.date.available | 2021-05-15T18:01:19Z | - |
dc.date.copyright | 2014-10-20 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-08-22 | |
dc.identifier.citation | 參考文獻
GINA: http://www.ginasthma.org/ 全民健康保險研究資料庫: http://nhird.nhri.org.tw/ 衛生福利部中央健康保險署: http://www.nhi.gov.tw/ 臺灣氣喘衛教學會: http://www.asthma-edu.org.tw/asthma/ 臺灣氣喘諮詢協會: http://www.taiwanasthma.com.tw/download_04.htm Akinbami, L. J., Moorman, J. E., Garbe, P. L., & Sondik, E. J. (2009). Status of childhood asthma in the United States, 1980–2007. Pediatrics, 123(Supplement 3), S131-S145. Akinbami, L. J., & Schoendorf, K. C. (2002). Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics, 110(2), 315-322. Arnold, E., Clark, C. E., Lasserson, T. J., & Wu, T. (2008). Herbal interventions for chronic asthma in adults and children. Cochrane Database Syst Rev, 1. Asher, M., Keil, U., Anderson, H., Beasley, R., Crane, J., Martinez, F., . . . Stewart, A. (1995). International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. European Respiratory Journal, 8(3), 483-491. Barnes, P. M., Powell-Griner, E., McFann, K., & Nahin, R. L. (2004). Complementary and alternative medicine use among adults: United States, 2002. Bateman, E., Hurd, S., Barnes, P., Bousquet, J., Drazen, J., FitzGerald, M., . . . Pedersen, S. (2008). Global strategy for asthma management and prevention: GINA executive summary. European Respiratory Journal, 31(1), 143-178. Beasley, R. (1998). Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The Lancet, 351(9111), 1225-1232. Burney, P., Luczynska, C., Chinn, S., & Jarvis, D. (1994). The European community respiratory health survey. European Respiratory Journal, 7(5), 954-960. Carlton, B. G., Lucas, D. O., Ellis, E. F., Conboy-Ellis, K., Shoheiber, O., & Stempel, D. A. (2005). The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices. Journal of Asthma, 42(7), 529-535. Chan, C. K., Kuo, M. L., Shen, J. J., See, L. C., Chang, H. H., & Huang, J. L. (2006). Ding Chuan Tang, a Chinese herb decoction, could improve airway hyper‐responsiveness in stabilized asthmatic children: a randomized, double‐blind clinical trial*. Pediatric Allergy and Immunology, 17(5), 316-322. Chang, L. C., Huang, N., Chou, Y. J., Lee, C. H., Kao, F. Y., & Huang, Y. T. (2008). Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003. BMC health services research, 8(1), 170. Chen, C.-Y., Chiu, H.-F., Yeh, M.-K., Chang, C.-C., & Yang, C.-Y. The use of anti-asthmatic medications among pediatric patients in Taiwan. [Comparative Study]. [鍵入文字] - 61 - Pharmacoepidemiology & Drug Safety, 12(2), 129-133. Chen, F. P., Chen, T. J., Kung, Y. Y., Chen, Y. C., Chou, L. F., Chen, F. J., & Hwang, S. J. (2007). Use frequency of traditional Chinese medicine in Taiwan. BMC health services research, 7(1), 26. Clark, C., Arnold, E., Lasserson, T., & Wu, T. (2010). Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysis. Prim Care Respir J, 19(4), 307-314. Ernst, E. (2000). Prevalence of use of complementary/alternative medicine: a systematic review. Bulletin of the World Health Organization, 78(2), 258-266. GINA_Report2011. <GINA_Report_2010.pdf>. Hsieh, K. H. (1996). Evaluation of efficacy of traditional Chinese medicines in the treatment of childhood bronchial asthma: clinical trial, immunological tests and animal study. Pediatric Allergy and Immunology, 7(3), 130-140. Hsieh, S. C., Lai, J. N., Lee, C. F., Hu, F. C., Tseng, W. L., & Wang, J. D. (2008). The prescribing of Chinese herbal products in Taiwan: a cross‐sectional analysis of the national health insurance reimbursement database. Pharmacoepidemiology and drug safety, 17(6), 609-619. Hwang, C.-Y., Chen, Y.-J., Lin, M.-W., Chen, T.-J., Chu, S.-Y., Chen, C.-C., . . . Liu, H.-N. Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan: a national study 2000 to 2007. [Research Support, Non-U.S. Gov't]. Acta Dermato-Venereologica, 90(6), 589-594. Jepson, G., Butler, T., Gregory, D., & Jones, K. (2000). Prescribing patterns for asthma by general practitioners in six European countries. Respiratory medicine, 94(6), 578-583. Kao, C.-C., Huang, J.-L., Ou, L.-S., & See, L.-C. The prevalence, severity and seasonal variations of asthma, rhinitis and eczema in Taiwanese schoolchildren. Pediatric Allergy & Immunology, 16(5), 408-415. Kao, S., Wang, S., Yu, C., Lei, H., & Wang, J. (2000). The effect of Chinese herbal medicine, xiao‐qing‐long tang (XQLT), on allergen‐induced bronchial inflammation in mite‐sensitized mice. Allergy, 55(12), 1127-1133. Kao, S. T., Lin, C. S., Hsieh, C. C., Hsieh, W. T., & Lin, J. G. (2001). Effects of xiao‐qing‐long‐tang (XQLT) on bronchoconstriction and airway eosinophil infiltration in ovalbumin‐sensitized guinea pigs: in vivo and in vitro studies. Allergy, 56(12), 1164-1171. Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002). Recent patterns of medication use in the ambulatory adult population of the United States. JAMA: the journal of the American Medical Association, 287(3), 337-344. Lee, K. H., Yeh, M. H., Kao, S. T., Hung, C. M., Chen, B. C., Liu, C. J., & Yeh, C. C. (2009). Xia-Bai-San inhibits lipopolysaccharide-induced activation of intercellular adhesion molecule-1 and nuclear factor-kappa B in human lung cells. Journal of ethnopharmacology, 124(3), 530-538. Li, X. M., & Brown, L. V. (2009). Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy. Journal of Allergy and Clinical Immunology, 123(2), 297-306. Liao, M.-F., Huang, J.-L., Chiang, L.-C., Wang, F.-Y., & Chen, C.-Y. Prevalence of asthma, rhinitis, and eczema from ISAAC survey of schoolchildren in Central Taiwan. Journal of Asthma, 42(10), 833-837. MacKian, S. (2003). A review of health seeking behaviour: problems and prospects. Health Systems Development. University of Manchester, Manchester, UK. Masoli, M., Fabian, D., Holt, S., & Beasley, R. (2004). The global burden of asthma: executive [鍵入文字] - 62 - summary of the GINA Dissemination Committee report. Allergy, 59(5), 469-478. Navaratnam, P., Jayawant, S. S., Pedersen, C. A., & Balkrishnan, R. (2008). Physician adherence to the national asthma prescribing guidelines: evidence from national outpatient survey data in the United States. Annals of Allergy, Asthma & Immunology, 100(3), 216-221. Passalacqua, G., Bousquet, P. J., Carlsen, K. H., Kemp, J., Lockey, R. F., Niggemann, B., . . . Bousquet, J. (2006). ARIA update: I—Systematic review of complementary and alternative medicine for rhinitis and asthma. Journal of Allergy and Clinical Immunology, 117(5), 1054-1062. Shen, J., & Oraka, E. (2011). Complementary and alternative medicine (CAM) use among children with current asthma. Preventive Medicine. Shenfield, G., Lim, E., & Allen, H. (2002). Survey of the use of complementary medicines and therapies in children with asthma. Journal of paediatrics and child health, 38(3), 252-257. SLADER, C. A., REDDEL, H. K., JENKINS, C. R., ARMOUR, C. L., & BOSNIC‐ANTICEVICH, S. Z. (2006). Complementary and alternative medicine use in asthma: who is using what? Respirology, 11(4), 373-387. Stafford, R. S., Ma, J., Finkelstein, S. N., Haver, K., & Cockburn, I. (2003). National trends in asthma visits and asthma pharmacotherapy, 1978-2002. Journal of Allergy and Clinical Immunology, 111(4), 729-735. Strachan, D., Sibbald, B., Weiland, S., Ait‐Khaled, N., Anabwani, G., Anderson, H. R., . . . Burr, M. (1997). Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatric Allergy and Immunology, 8(4), 161-168. Sun, H. L., Kao, Y. H., Chou, M. C., Lu, T. H., & Lue, K. H. (2006). Differences in the prescription patterns of anti-asthmatic medications for children by pediatricians, family physicians and physicians of other specialties. Journal of the Formosan Medical Association, 105(4), 277-283. Tai, C. C. (2008). Pediatric asthma and medical resources utilization. Thomas, M., Murray-Thomas, T., Fan, T., Williams, T., & Taylor, S. (2010). Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study. BMC pulmonary medicine, 10(1), 29. Yeh, K.-W., Chen, S.-H., Chiang, L.-C., Chen, L.-C., & Huang, J.-L. Survey of asthma care in Taiwan: a comparison of asthma specialists and general practitioners. [Comparative Study Research Support, Non-U.S. Gov't]. Annals of Allergy, Asthma, & Immunology, 96(4), 593-599. Yeh, K.-W., Chiang, L.-C., & Huang, J.-L. Epidemiology and current status of asthma and associated allergic diseases in Taiwan- ARIA Asia-Pacific Workshop report. Asian Pacific Journal of Allergy & Immunology, 26(4), 257-264. 方俞尹. (2009). 全民健康保險氣喘醫療給付改善方案長期影響評估. 臺灣大學. Available from Airiti AiritiLibrary database. 王人澍, 高尚德, & 鄭啟清. (2008). Treatment of Asthma based on the Syndrome Differentiation Theory. 臺灣中醫臨床醫學雜誌. 王筱蓉. (2010). 2002年台灣全民健保氣喘病患之中醫醫療利用. 中國醫藥大學. Available from Airiti AiritiLibrary database. 史麗珠, 彭佩宜, 高鳳聲, 蘇靖鈞, 鄭蔥君, & 李幸禧. (2000). 北部某大學學生的求醫行為:中西醫之選擇. 秀傳醫學雜誌. 石怡馨. (2010). 加入全民健保論質計酬計畫之氣喘病患者接受中西醫療法與照護結果之相關. 中國醫藥大學. Available from Airiti AiritiLibrary database. 余建玮, 薛汉荣, 洪广祥, & 程光宇. (2007). 中医药防治哮喘与Th1/Th2的平衡调节. [鍵入文字] - 63 - [Prevention and Treatment of Asthma by Traditional Chinese Medicine by Re-Balancing Th1/Th2]. 中華中醫藥學刊, 25(11), 2277-2279. 吳家興, 林瑞雄, 謝貴雄, 邱文達, 陳麗美, 邱淑媞, . . . 蕭慧娟. (1998). 台灣北部國中學生氣喘盛行率調查. 中華公共衛生雜誌, 17(3), 214-225. 呂克桓, & 謝貴雄. (1988). 臺北市學童過敏病:11年間之變化. Acta Paediatrica Sinica. 林玉彩. (2011). 中醫小兒氣喘試辦計畫對醫療資源耗用差異之研究. 碩士, 中臺科技大學, 台中市. Retrieved from http://ndltd.ncl.edu.tw/cgi-bin/gs32/gsweb.cgi?o=dnclcdr&s=id=%22099CTC05743024%22.&searchmode=basic 林谷峯. (2004). 以全民健保1996-2001年承保抽樣歸人檔分析氣喘病人之醫療利用. 臺灣大學. Available from Airiti AiritiLibrary database. 林宜柏, 徐敏芳, 鄭世隆, & 王鶴健. (2008). “氣喘醫療給付改善方案” 實施成效之探討. 亞東學報(28_S), 57-64. 邱晨, 高伟良, 高雪, 李富荣, & 陈华青. (2007). 中药小青龙汤对哮喘气道平滑肌细胞周期调控机制的影响. 中國醫師雜誌. 張巧怡. (2008). 中西醫聯合照護於小兒氣喘病患之生活品質及成本效果之評估. 中國醫藥大學. Available from Airiti AiritiLibrary database. 張立德, 林佑蓉, & 唐進勝. (2006). 台北縣八鄉鎮國小學童氣喘盛行率之調查. 輔仁醫學期刊, 4(2), 61-72. 曹永昌. (2009). 小兒氣喘的中醫療法. 中醫兒科醫學雜誌. 許清祥, 徐昀耀, & 李明憲. (2000). 中醫平喘方劑對於過敏原特異性呼吸道發炎反應的作用機轉評估. 中醫藥雜誌, 11(3), 111-121. 許毓芬. (2007). 氣喘之中醫治療. 北市醫學雜誌. 郭育良. (2001). 台灣地區六至十四歲學生氣喘盛行率調查. 陳潮宗. (2002). 氣喘病的中醫論治. 中醫藥研究論叢. 楊賢鴻. (2008). 小青龍湯對氣喘免疫調節研究. 中醫藥研究論叢. 萬玉鳳. (2005). 小兒氣喘. 臺灣中醫臨床醫學雜誌. 廖佩珊, 陳建霖, 謝一紅, & 侯毓昌. (2010). 中醫醫療服務品質研究-以「小兒氣喘緩解期中醫優質門診照護試辦計畫」為例. 中西整合醫學雜誌. 廖美芬. (2003). 彰化縣國小學童氣喘過敏盛行率調查. 臺灣兒童過敏氣喘及免疫學會學會通訊. 劉尚志, & 謝慶良. (2004). 智慧財產權規範與中草藥技術發展之研究. 劉貞娟, 翁慧卿, & 蔡魯. (2006). 氣喘疾病管理在醫療資源耗用、臨床指標改善與自我照護能力的影響. 福爾摩莎醫務管理雜誌. 蔡文正, 衛生學, 張永賢, & 中藥學. (2007). 民眾對中醫藥的認知度, 信賴度, 使用度及其相關因素之探討: 行政院衛生署中醫藥委員會. 簡慈美. (2006). 台灣全民健保中醫用藥分析研究(2002-2003). 中國醫藥大學. Available from Airiti AiritiLibrary database. 蘇有村, 陳國俊, 吳展耀, 翁慧卿, 陳施如, 劉惠君, . . . 牛震廣. (2008). 全民健康保險氣喘醫療給付改善方案改善多數兒童氣喘疾病嚴重度. 中華民國兒童胸腔醫學會雜誌. 陈玉娟, 刘琳, 段长利, & 宋素贞. (2008). 中医药防治气道重建的研究进展. 陝西中醫. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5515 | - |
dc.description.abstract | 研究目的:
小兒門診氣喘病患處方箋中西藥物處方型態分析。 研究方法: 橫斷性(cross-sectional)描述研究。 研究結果: 2007年15歲以下、主診斷為氣喘之小兒門診氣喘病患共10,241人,其中,只看西醫10,068人(98.31%)、合併中西醫105人(1.03%)、只看中醫68人(0.66%)。年齡在8歲以上只用中醫以及合併中西醫的百分比(約6-9%)較8歲以下(約1-2%)的族群高。 年齡分佈以4歲至7歲的年齡層最多,共4,783人(約50%);性別分佈男性約60%、女性約40%。醫療院所層級以基層診所最多(約70%);健保分局別以台北分局為主(約30%),東區分局在4-7歲以及8-11歲族群只用中醫以及合併中西醫的百分比高於其他分局(6-9%)。 就醫科別方面,只看西醫部分,0-3歲族群約有80%以小兒科為主、其他20%;4-7歲族群約有70%以小兒科為主、其他30%;8-11歲族群約有65%以小兒科為主、35%其他;12-15歲族群約有50%以小兒科為主、其他50%。 共病症方面,次診斷有過敏性鼻炎或是異位性皮膚炎的診斷,當年度有共病症診斷約20-30%、沒有共病症約70-80%,只看中醫的病患共病症的百分比低於只看西醫以及合併中西醫的百分比。 當年度急診及住院的醫療利用方面,當年度曾經使用急診或住院的診斷約25%、沒有使用約75%,12-15歲族群使用急診和住院的百分比最少。 平均處方箋數方面,只看西醫部分以4-7歲平均處方箋3.04張最多;合併中西醫部分以8-11歲平均處方箋8.84張最多;只看中醫部分以4-7歲平均處方箋3.52張最多。 小兒門診氣喘病患總處方箋共28,517張,只用西藥27,532張處方箋(96.55%)、只用中藥199張處方箋(0.70%)、合併中西藥786張處方箋(2.75%);參加「全民健康保險氣喘醫療給付改善方案」處方箋5,821張(20.90%)、未參加處方箋22,181張(70.10%);參加「小兒氣喘緩解期中醫優質門診照護試辦計畫」41張處方箋(8.63%)、未參加434張處方箋(91.27%)。 處方開立氣喘西藥劑型部份,只用西藥處方箋與合併中西藥的處方箋當中,開立吸入劑型最少(分別為7%、10%)、開立口服劑型最多(分別為76%、64%)、開立吸入加口服劑型次之(分別為17%、26%)。在參加或未參加「全民健康保險氣喘醫療給付改善方案」的處方箋當中,開立吸入劑型最少(分別為13%、5%)、開立口服劑型最多(68%、78%)、開立吸入加口服劑型次之(19%、17%)。 處方開立氣喘西藥數量部分,在只用西藥處方箋與合併中西藥處方箋皆以開立一種氣喘用藥為主(分別為48%及33%)。在參加或未參加「全民健康保險氣喘醫療給付改善方案」的處方箋當中,也是開立一種氣喘用藥最多(分別為54%和47%)。 處方開立氣喘西藥排名,在只用西藥和中西藥並用處方箋中,口服乙型交感神經興奮劑在只用西藥的處方箋排名第一(20%);白三烯受體拮抗劑與口服乙型交感神經興奮劑、口服類固醇類加上口服乙型交感神經興奮劑三種氣喘用藥皆為並用中西藥排名第一的藥品(各為11%)。在參加或未參加「全民健康保險氣喘醫療給付改善方案」的處方箋當中,參加組以白三烯受體拮抗劑最多(23%)、未參加組以口服乙型交感神經興奮劑最多(23%)。 處方開立氣喘中藥複方數量方面,在只用中藥和合併中西藥的處方箋當中,以開立一種氣喘中藥複方的處方箋為主(80%及62%)。在參加或未參加「小兒氣喘緩解期中醫優質門診照護試辦計畫」處方箋當中,也是以開立一種氣喘中藥複方為主(61 %與70%)。 處方開立氣喘中藥複方排名,在只用中藥處方箋中,排名第一為治療氣喘實症的小青龍湯(30%)、在合併中西藥處方箋中排名第一的為治療氣喘實症的定喘湯(20%)。在參加「小兒 [鍵入文字] v 氣喘緩解期中醫優質門診照護試辦計畫」排名第一的是治療氣喘虛症的蘇子降氣湯(44%)、未參加組排名第一的是治療實症小青龍湯( 24%)。 結論: 小兒氣喘門診病患共10,241人,以男性、4歲至7歲、基層診所、台北健保分局為主要的分佈族群,就醫科別以小兒科為主,沒有共病症、當年度沒有使用急診或住院的人數百分比多於有共病症以及有使用急診或住院的人數百分比。在8歲以上的族群使用中醫或合併中西醫的百分比大於8歲以下的族群。 小兒門診氣喘處方箋共28,517張,只用西藥27,532張處方箋、只用中藥199張處方箋、合併中西藥786張處方箋。在只用西藥或合併中西藥的處方箋皆以開立一種氣喘西藥為主,最常使用的為口服乙型交感神經興奮劑;只用中藥或合併中西藥的處方箋氣喘中藥以開立一種氣喘中藥複方為主,最常使用的為治療實症的氣喘用藥小青龍湯或定喘湯。 參加或未參加「全民健康保險氣喘醫療給付改善方案」處方箋用藥型態比較,參加組使用吸入型氣喘西藥的百分比高於未參加組,且用藥排名有差異,參加組用藥排名以白三烯受體拮抗劑為主、未參加組以口服乙型交感神經興奮劑為主。 參加或未參加「小兒氣喘緩解期中醫優質門診照護試辦計畫」處方箋用藥型態比較,參加組用藥排名以治療氣喘虛症的蘇子降氣湯為主、未參加組以治療氣喘實症的小青龍湯為主。 | zh_TW |
dc.description.abstract | Objective:
To analyze the outpatient characteristics and prescription patterns of younger asthma patients’ of both Chinese and Western medicine. Methods: Cross- sectional study Results: There are tatal 10,241 younger asthma patients devided in 3 seeking behavior: using Western medicine only (98.31%), using Chinese medicine only (0.66%) and using both Western and Chinese medicine (1.03%). The age devided in 4 groups: 0-3,4-7,8-11,12-15 years old, the 4-7 years old group having the most patients (4,783,46.70%).The 8-11 and 12-15 years old group has more percentage of using both Chinese and Western medicine and using Chinese medicine only (3%) compare to the 0-3 and 4-7 years old group(1%). The younger asthma patients’ gender percentage of male is 60% and female is 40%. Most of patients seeking for doctors in pediatric clinics (70%) at Taipei (30%). The 4-7 and 8-11 years old asthma patients having more percentage (6%) in using Chinese medicine in Eastern part of Taiwan. The percentage of younger asthma patients in ER and inpatient is about 30%, and the percentage of atopic dermatitis or allergic rhinitis co-diease is about 25%. The total prescriptions of younger asthma patients are 28,517, 27,532 using Western medicine only(96.70%), 199 using Chinese medicine only(0.55%); 786 using both Western and Chinese medicine(2.75%). Among these prescriptions, 5,821 attending the Western medicine pay-for-performance program(20.90%); 41 attending the Chinese medicine pay-for-performance program(8.63%). The prescription of inhaled type antiasthmatic medicine using in the Western medicine only group and both Western and Chinese medicine group are about 10%, the oral type are about 70%, and about 20% are both inhaled and oral type antiasthmatic medicine. The prescriptions of inhaled type antiasthmatic medicine using in the attending Western pay-for-performance group are about 13% but 5% in not attending group, the oral type antiasthmatic medicine using in the attending group are about 68% but 78% in not attending group, and using both inhaled and oral type antiasthmatic medicine are about 19% in attending group and 17% in not attending group. The total prescriptions usually have 1 antiasthmatic medicine, the number 1 antiasthmatic medicine in using Western medicine only group are oral beta-2 agonists(20%), and leukotrienes ,oral beta-2 agonists and oral corticosteroids plus oral beta-2 agonist are both the number 1 antiasthmatic medicine using both Western and Chinese medicine group(11%). The number 1 antiasthmatic medicine in attending Western pay-for-performance group are leukotrienes(23%), but the number 1 antiasthmatic medicine in not attending group are oral beta-2 agonists. The number 1 antiasthmatic Chinese medicine complex in using Chinese medicine only group are Xiao-Qing-Long Tang(30%) , and Ding-Tran-Tang are the number 1 antiasthmatic Chinese medicine complex in both using Chinese and Western medicine group.(20%). The number 1 antiasthmatic Chinese medicine complex in attending the Chinese pay-for-performance group are Suzi-Jiang-Qi-Tang(44%) and the Xiao-Qing-Long Tang in not attending group(24%). Conclusions: [鍵入文字] viii The total outpatient younger asthma patients are 10,241 in 2007, 4-7 years old male in Taiper clinics are the main groups about these patients.The patients senior than 8 years old using Chinese medicine more then the patients who younger than 8 years old. The prescription patterns of these patients are usually prescribed one antiasthmatic medicine, and the oral beta-2 agonists are the number 1 medicine. The prescription patterns of these patients are usually prescribed one antiasthmatic Chinese medicine complex,the “shizheng” medicine (Xiao-Ching-Long Tang and Ding-Tran-Tang) are the number 1 antiasthmatic Chinese medicine complex in one prescription. In attending Western pay-for-performance group’s prescriptions, the inhaled type of antiasthmatic medicine having more percentage than not attending group, and the number 1 antiasthmatic medicine are not the same. In attending Chinese pay-for-performance group’s prescriptions, the number 1 antiasthmatic Chinese medicine complex are not the same compare with not attending group. | en |
dc.description.provenance | Made available in DSpace on 2021-05-15T18:01:19Z (GMT). No. of bitstreams: 1 ntu-103-R99849041-1.pdf: 3818678 bytes, checksum: b0ce49e21cc7c44e57a4dc92ae455192 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 中文摘要 ......................................... i
英文摘要 ......................................... iv 目錄 ............................................. vii 表目錄 ........................................... ix 第一章 前言 ...................................... 1 第一節 研究背景 ................................... 1 第二節 研究重要性 ................................. 2 第三節 研究目的 ................................... 3 第二章 文獻探討 .................................. 44 第一節 兒童氣喘盛行率 ............................. 4 第二節 小兒門診氣喘病患就醫行為、氣喘政策與醫療利用 .....................................................6 第三節 小兒門診氣喘病患處方箋氣喘西藥處方用藥型態 ...10 第四節 小兒門診氣喘病患氣喘中藥複方處方用藥型態 .....18 第五節 小結 ........................................ 24 第三章 研究方法 ................................... 25 第一節 研究資料來源 ................................ 25 第二節 研究變項與統計分析 .......................... 26 第四章 研究結果 ................................... 32 第一節 小兒門診氣喘病患就醫行為特質描述性分析 .......32 第二節 小兒門診氣喘病患處方箋西藥處方型態分析 ...... 43 第三節 小兒門診氣喘病患處方箋中藥複方處方型態分析 第五章 討論與結論 .................................55 第一節 討論 ........................................ 55 第二節 結論 ........................................ 57 參考文獻 ........................................... 60 附錄 ............................................... 63 | |
dc.language.iso | zh-TW | |
dc.title | 以臺灣健保資料庫探討小兒門診氣喘病患中西藥處方型態 | zh_TW |
dc.title | The Prescription Patterns of Western and Chinese Medicine
of Young Asthma Patients Using Taiwan National Health Insurance Claim Data | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 簡國龍,季瑋珠 | |
dc.subject.keyword | 氣喘,論質計酬,處方型態,氣喘西藥,氣喘中藥複方, | zh_TW |
dc.subject.keyword | asthma,prescription pattern,antiasthmatic agents, | en |
dc.relation.page | 69 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2014-08-22 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf | 3.73 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。